Market Cap

SinoMab BioScience Ltd Market Capitalization:

HK$1.71 Billion

HKD as of Jan. 1, 2024

US$218.7 Million

business SinoMab BioScience Ltd Company Profile

SinoMab BioScience Ltd Main Stock Listing

HKEX: 3681

Market Capitalization History of SinoMab BioScience Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of SinoMab BioScience Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 HK$1.71 B -19.95%
Jan. 1, 2023 HK$2.13 B -19.39%
Jan. 1, 2022 HK$2.65 B -41.43%
Jan. 1, 2021 HK$4.52 B 8.45%
Jan. 1, 2020 HK$4.17 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

SinoMab BioScience Ltd Categories

Hong Kong languages Healthcare languages Biotechnology
Hong Kong Healthcare Hong Kong Biotechnology

Stocks & Indices

SinoMab BioScience Ltd has the following listings and related stock indices.


Stock: HKEX: 3681

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.